Approvals/CIMA-AEMPS/FRAXIPARINA 9.500 UI ANTI Xa/ML SOLUCION INYECTABLE VIAL MULTIDOSIS

Approved

STANDARD

FRAXIPARINA 9.500 UI ANTI Xa/ML SOLUCION INYECTABLE VIAL MULTIDOSIS

Aspen Pharma Trading Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 77eb936fd36fc9a9
Drug Cima Aemps Name: FRAXIPARINA 9.500 UI ANTI Xa/ML SOLUCION INYECTABLE VIAL MULTIDOSIS
Register Number: 86000
Holder Company Name: Aspen Pharma Trading Limited
Marketing Company Name: Aspen Pharma Trading Limited
Holder Company Detail Path: /organization/aspen-pharma-trading-limited
Marketing Company Detail Path: /organization/aspen-pharma-trading-limited
Authorization Date: 2021-06-02
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 9.500 anti-Xa IU/ml
Route Of Administration: VÍA INTRAVENOSA, VÍA SUBCUTÁNEA, USO EXTRACORPORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Aspen Pharma Trading Limited
Company Detail Path: /organization/aspen-pharma-trading-limited

NADROPARINA CALCICA

9.500 anti-Xa UI/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 2, 2021

Approval ID

77eb936fd36fc9a9

Type

Standard